Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
doi: 10.1097/qad.0000000000000869 207 RofaelSADBrownJPickettEJohnsonMHurstJRSprattDet al
Observational Evidence for GLP-1RAs Real-world data in ARDs, particularly rheumatoid arthritis and systemic lupus erythematosus, suggest GLP-1RA use is associated with lower rates of major adverse cardiovascular events and all-cause mortality, mirroring findings in broader populations
Najafi, S., Bahrami, M., Butler, A
Whether chronic use affects normal age-related changes in metabolism, body composition, or health cannot be determined from current data
US$ 25.62
US$ 25.26
US$ 29.24
US$ 20.13
US$ 27.96
US$ 22.51
